KHIRON LIFE SCIENCES CORP (KHRN.CA) Stock Price, Forecast & Analysis

Canada TSX Venture Exchange TSX-V:KHRN • CA49374L3065

0.04 CAD
0 (0%)
Last: May 5, 2023, 07:00 PM

KHRN.CA Key Statistics, Chart & Performance

Key Statistics
Market Cap7.19M
Revenue(TTM)16.14M
Net Income(TTM)-30.66M
Shares179.71M
Float172.30M
52 Week High0.21
52 Week Low0.04
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-0.17
PEN/A
Fwd PEN/A
Earnings (Next)N/A
IPO2012-10-25
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals
KHRN.CA short term performance overview.The bars show the price performance of KHRN.CA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -20 -40 -60

KHRN.CA long term performance overview.The bars show the price performance of KHRN.CA in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60

The current stock price of KHRN.CA is 0.04 CAD. In the past month the price decreased by -11.11%. In the past year, price decreased by -75%.

KHIRON LIFE SCIENCES CORP / KHRN Daily stock chart

KHRN.CA Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating
KHRN.CA Full Technical Analysis Report

KHRN.CA Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to KHRN.CA. KHRN.CA has a bad profitability rating. Also its financial health evaluation is rather negative.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
KHRN.CA Full Fundamental Analysis Report

KHRN.CA Financial Highlights

Over the last trailing twelve months KHRN.CA reported a non-GAAP Earnings per Share(EPS) of -0.17. The EPS decreased by -59.04% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA N/A
ROE N/A
Debt/Equity 0.05
Chartmill High Growth Momentum
EPS Q2Q%11.56%
Sales Q2Q%-3.82%
EPS 1Y (TTM)-59.04%
Revenue 1Y (TTM)38.2%
KHRN.CA financials

KHRN.CA Forecast & Estimates

7 analysts have analysed KHRN.CA and the average price target is 0.1 CAD. This implies a price increase of 155% is expected in the next year compared to the current price of 0.04.

For the next year, analysts expect an EPS growth of 39.13% and a revenue growth 36.43% for KHRN.CA


Analysts
Analysts45.71
Price Target0.1 (150%)
EPS Next Y39.13%
Revenue Next Year36.43%
KHRN.CA Analyst EstimatesKHRN.CA Analyst Ratings

KHRN.CA Ownership

Ownership
Inst Owners1.47%
Ins OwnersN/A
Short Float %N/A
Short RatioN/A
KHRN.CA Ownership

KHRN.CA Competitors/Peers

The largest stocks on the Canadian markets in the "Pharmaceuticals" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
BHC BAUSCH HEALTH COS INC1.433.019B
GSD DEVONIAN HEALTH GROUP INC N/A1.659B
CRON CRONOS GROUP INC37.361.367B
TLRY TILRAY BRANDS INC N/A1.211B
DHT-UN DRI HEALTHCARE TRUST7.02902.702M
GUD KNIGHT THERAPEUTICS INC122.36590.775M
WEED CANOPY GROWTH CORP N/A552.69M
NGEN NERVGEN PHARMA CORP N/A393.546M
CPH CIPHER PHARMACEUTICALS INC26.94370.148M
TSND TERRASCEND CORP N/A331.425M

About KHRN.CA

Company Profile

KHRN logo image Khiron Life Sciences Corp. is a vertically integrated medical and consumer packaged goods (CPG) cannabis company with core operations in Latin America and operational activities in Europe and North America. The company is headquartered in Toronto, Ontario and currently employs 310 full-time employees. The company went IPO on 2012-10-25. The Company’s product lines include medical cannabis products, health services and wellbeing products. The medical cannabis product sells branded medical cannabis products. The health service operates its own network of medium complexity health centers (operating under the ILANS and Zerenia brands) and Zerenia satellite clinics offering a range of health, medical and surgical services in alignment with insurance company partners. Its wellbeing product is focused on delivering the benefits of cannabidiol (CBD) a range of various branded consumer packaged goods, such as its Kuida cosmetics line. The firm provides patient-oriented approach, physician education programs, scientific expertise, product innovation, and agricultural infrastructure. The firm sells its products in Colombia, Peru, Germany, United Kingdom and Brazil.

Company Info

KHIRON LIFE SCIENCES CORP

100 King St.W., Suite 1600, 1 First Canadian Place

TORONTO ONTARIO V6C 2B5 CA

CEO: Alvaro Torres

Employees: 310

KHRN Company Website

Phone: 17055273564.0

KHIRON LIFE SCIENCES CORP / KHRN.CA FAQ

What does KHIRON LIFE SCIENCES CORP do?

Khiron Life Sciences Corp. is a vertically integrated medical and consumer packaged goods (CPG) cannabis company with core operations in Latin America and operational activities in Europe and North America. The company is headquartered in Toronto, Ontario and currently employs 310 full-time employees. The company went IPO on 2012-10-25. The Company’s product lines include medical cannabis products, health services and wellbeing products. The medical cannabis product sells branded medical cannabis products. The health service operates its own network of medium complexity health centers (operating under the ILANS and Zerenia brands) and Zerenia satellite clinics offering a range of health, medical and surgical services in alignment with insurance company partners. Its wellbeing product is focused on delivering the benefits of cannabidiol (CBD) a range of various branded consumer packaged goods, such as its Kuida cosmetics line. The firm provides patient-oriented approach, physician education programs, scientific expertise, product innovation, and agricultural infrastructure. The firm sells its products in Colombia, Peru, Germany, United Kingdom and Brazil.


Can you provide the latest stock price for KHIRON LIFE SCIENCES CORP?

The current stock price of KHRN.CA is 0.04 CAD.


What is the dividend status of KHIRON LIFE SCIENCES CORP?

KHRN.CA does not pay a dividend.


What is the ChartMill technical and fundamental rating of KHRN stock?

KHRN.CA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


How is the valuation of KHIRON LIFE SCIENCES CORP (KHRN.CA) based on its PE ratio?

KHIRON LIFE SCIENCES CORP (KHRN.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.17).


What is the expected growth for KHRN stock?

The Revenue of KHIRON LIFE SCIENCES CORP (KHRN.CA) is expected to grow by 36.43% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.


What is the market capitalization of KHRN stock?

KHIRON LIFE SCIENCES CORP (KHRN.CA) has a market capitalization of 7.19M CAD. This makes KHRN.CA a Nano Cap stock.